MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ACXP Acurx Pharmaceuticals
- 0.825
- +0.067+8.77%
Close Dec 20 16:00 ET
- 0.830
- +0.005+0.61%
Post 16:56 ET
13.94MMarket Cap-0.76P/E (TTM)
0.835High0.760Low100.69KVolume0.790Open0.759Pre Close81.18KTurnover0.70%Turnover RatioLossP/E (Static)16.89MShares5.28052wk High5.22P/B11.95MFloat Cap0.72052wk Low--Dividend TTM14.49MShs Float8.820Historical High--Div YieldTTM9.88%Amplitude0.720Historical Low0.806Avg Price1Lot Size
Acurx Pharmaceuticals News
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scodari Joseph C
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRISON THOMAS L
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Donohue James J.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEAN JACK H
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shawah Robert G.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Acurx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Donohue James J.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRISON THOMAS L
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEAN JACK H
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scodari Joseph C
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.